Prostatic acid phosphatase was labeled by four different iodination procedures: chloramine-T, insoluble or soluble lactoperoxidase, and Bolton-Hunter. Enzyme labeled by the chloramine-T procedure had suboptimal precipitation characteristics in immunoassays, with 36 to 67% of the tracer precipitated in antibody excess. Analysis of the tracer on 7.5% sodium dodecyl sulfate polyacrylamide gel showed that as much as 30% of the radioactivity migrated away from the protein within 6 minutes after the electrophoretic run was begun. The nature of this fast migrating radioiodinated component was not determined. The failure to obtain a tracer labeled by the chloramine-T procedure with optimal immunoprecipitation characteristics led to investigation of alternate radioiodination procedures. Insoluble or soluble lactoperoxidase was less effective than chloramine-T in producing a tracer suitable for radioimmunoassay. In contrast, the Bolton-Hunter procedure produced a tracer that had optimal precipitation characteristics; 88 to 91% of the tracer was precipitated in antibody excess. The tracer was further purified by affinity chromatography to minimize the possibility of other protein contaminants compromising the specificity of a radioimmunoassay for the enzyme.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0009-8981(83)90006-2DOI Listing

Publication Analysis

Top Keywords

prostatic acid
8
acid phosphatase
8
insoluble soluble
8
soluble lactoperoxidase
8
labeled chloramine-t
8
chloramine-t procedure
8
precipitation characteristics
8
tracer precipitated
8
precipitated antibody
8
antibody excess
8

Similar Publications

The radiotracer [F]JK-PSMA-7, a prostate cancer imaging agent for positron emission tomography (PET), was previously synthesized by indirect radiofluorination using an F-labeled active ester as a prosthetic group, which had to be isolated and purified before it could be linked to the pharmacologically active Lys-urea-Glu motif. Although this procedure could be automated on two-reactor modules like the GE TRACERLab FX2N (FXN) to afford the tracer in modest radiochemical yields (RCY) of 18-25%, it is unsuitable for cassette-based systems with a single reactor. To simplify implementation on an automated synthesis module, the radiosynthesis of [F]JK-PSMA-7 was devised as a one-pot, two-step reaction.

View Article and Find Full Text PDF

Cellular Signaling of Amino Acid Metabolism in Prostate Cancer.

Int J Mol Sci

January 2025

School of Biology and Biological Engineering, South China University of Technology, University Town, Guangzhou 510006, China.

Prostate cancer is one of the most common malignancies affecting men worldwide and a leading cause of cancer-related mortality, necessitating a deeper understanding of its underlying biochemical pathways. Similar to other cancer types, prostate cancer is also characterised by aberrantly activated metabolic pathways that support tumour development, such as amino acid metabolism, which is involved in modulating key physiological and pathological cellular processes during the progression of this disease. The metabolism of several amino acids, such as glutamine and methionine, crucial for tumorigenesis, is dysregulated and commonly discussed in prostate cancer.

View Article and Find Full Text PDF

Bacterial prostatitis (BP) is a common prostatic infection characterized by pain and urinary symptoms, often with negative bacterial cultures from prostatic secretions. It affects young and older men bimodally and impacts quality of life (QoL) significantly. : Treatment typically involves antibiotics, but a multimodal approach with additional nutraceuticals may enhance outcomes.

View Article and Find Full Text PDF

The discovery of cisplatin (cisPt) as an effective anticancer agent was a milestone in the health industry. Despite its success, undesired side effects and acquired resistance still limit the therapeutic usefulness of cisPt. Intrastrand adduct formation at consecutive purines and structural modifications of DNA caused by platinum(II) complexes are important factors for antitumor efficacy.

View Article and Find Full Text PDF

Focal therapy offers a promising approach for treating localized prostate cancer (PC) with minimal invasiveness and potential cost benefits. High-intensity focused ultrasound (HIFU) and brachytherapy (BT) are among these options but lack long-term efficacy data. Patient follow-ups typically use biopsies and multiparametric MRI (mpMRI), which often miss recurrences.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!